你即將離開本站

並前往https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/asco-2020/

ASCO 2020 - Oncology Nurse Advisor

Obinutuzumab plus chemotherapy showed more durable efficacy, safety, and longer progression-free survival for patients with untreated follicular lymphoma. Novel ...

確定！ 回上一頁

查詢 「ASCO 2020」的人也找了：

  1. ASCO 2020
    2.
  2. ASCO Annual Meeting
    3.
  3. ASCO 2021
    4.
  4. ESMO
    5.
  5. ASCO 2022
    6.
  6. ASCO 2019
    7.
  7. ESMO 2020
    8.
  8. ASCO guideline
    9.